A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if the treatment combination of paclitaxel and
lovastatin is more effective than the currently available chemotherapy for refractory or
relapsed ovarian cancer. This research is being done to improve on currently available
chemotherapy for ovarian cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Iowa
Treatments:
Albumin-Bound Paclitaxel Dihydromevinolin L 647318 Lovastatin Paclitaxel